Pune-based Serum Institute of India (SII), the producer of the Covishield vaccine has utilized to the Drug Controller General of India (DCGI) looking for permission to fabricate COVID-19 vaccine Sputnik V within the nation, authorities sources stated on Thursday.
The Pune-based vaccine manufacturing agency has additionally sought approval for check evaluation and examination. The SII is at the moment manufacturing the Covishield doses and the Novavax vaccines.
“The Serum Institute of India (SII) put up an utility to the Drugs Controller General of India (DCGI) on Wednesday looking for permission to fabricate the COVID-19 vaccine, Sputnik V, in India,” a supply stated.
Russia’s Sputnik V vaccine is at the moment being manufactured in India by Dr Reddy’s Laboratories.
If the Drug Controller General of India grants permission then the Serum Institute of India (SII) will grow to be the seventh firm to fabricate Russia’s Sputnik V vaccine.
Russia’s RDIF sovereign wealth fund, which is advertising and marketing Sputnik V globally, has already signed agreements with six main Indian producers together with Dr Reddy’s Laboratories, Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, and Virchow Biotech.
The vaccine was given emergency use authorisation by the Drug Controller General of India in April. A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday. It was the third and largest supply of the imported COVID-19 vaccines.